Expression of SP-C was lost in undifferentiated regions of BrafCA/+; Lkb1flox/+-induced adenocarcinomas as well as Kras+/LSLG12Vgeo advanced tumors (Figure 4). Here, KRAS is linked to adenocarcinoma.